查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392386

全球体外毒性测试市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势和预测

Global In Vitro Toxicity Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 336 Pages | 商品交期: 最快1-2个工作天内

价格

全球体外毒性测试市场需求预计将从 2022 年的 13.46 万美元达到 2030 年近 34.34 万美元的市场规模，2023-2030 年研究期间CAGR为 12.42%。

体外毒性测试是基于研究的有毒化学物质对培养细菌或哺乳动物细胞影响的评估。体外研究（即在玻璃中）是针对正常生物条件之外的微生物、细胞或生物分子进行的。在体外测试药物时，药物的浓度被限制在已知的体积内。这一点至关重要，因为所有药物行为评估基本上都是按规定的比例进行论证的。这样做主要是为了评估药物开发的安全性和化学强度。毒性测试的目标是开发能够充分保护公众健康免受暴露于环境因素的不利影响的资料。

市场动态：

评估药物安全性的技术进步、消费品安全性的高涨、潜在药物排名和筛选的增加以及体外测试数量的增加是体外毒理学测试的关键行业驱动力。此外，研发投资的增加以及对动物试验的反对促使了体外毒理学测试。然而，政府的严格监管和专业人才的缺乏是体外测试的重大障碍。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球体外毒性测试市场的各个细分市场进行了包容性评估。体外毒性测试产业的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲体外毒性测试市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。体外毒性测试市场的主要参与者包括Thermo Fisher Scientific Inc.（美国）、Covance（美国）、Bio-Rad Laboratories, Inc.（美国）、GE Healthcare（美国）、Eurofins Scientific SE（卢森堡）、Merck KGaA（德国）、Charles River Laboratories International, Inc.（美国）、Catalent, Inc.（美国）、Cyprotex（英国）、SGS SA（瑞士）、QIAGEN NV（德国）、Promega Corporation（美国）、Gentronix Limited（英国） 、BioIVT（美国）和MB 研究实验室（美国）。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：体外毒性测试 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品和服务分類的市场吸引力分析
    • 市场吸引力分析方法
    • 按毒性终点和测试进行的市场吸引力分析
    • 按行业分類的市场吸引力分析
    • 按技术分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球体外毒性测试市场分析：按产品和服务分类

  • 按产品和服务分類的概述
  • 历史和预测数据
  • 按产品和服务分析
  • 新冠疫情影响
  • 耗材
  • 检测（细菌毒性检测、酵素毒性检测、基于细胞的 Elisa 和蛋白质印迹、受体结合检测、组织培养检测、其他检测）
  • 装置
  • 软体
  • 服务

第 7 章：全球体外毒性测试市场分析：依方法

  • 依方法概述
  • 历史和预测数据
  • 方法分析
  • 细胞分析
  • 生化检测
  • 电脑模型
  • 离体模型

第 8 章：全球体外毒性测试市场分析：依毒性终点和测试

  • 毒性终点和测试概述
  • 历史和预测数据
  • 毒性终点分析和测试
  • 阿德梅
  • 皮肤刺激、腐蚀和过敏
  • 遗传毒性测试
  • 细胞毒性测试
  • 眼部毒性
  • 器官毒性
  • 光毒性测试
  • 皮肤毒性
  • 其他毒性终点和测试

第 9 章：全球体外毒性测试市场分析：按行业

  • 行业概况
  • 历史和预测数据
  • 产业分析
  • 新冠疫情影响
  • 药品与生物製药
  • 化妆品及家居用品
  • 食物
  • 化学品

第 10 章：全球体外毒性测试市场分析：依技术分类

  • 依技术概述
  • 历史和预测数据
  • 依技术分析
  • 细胞培养技术
  • 高通量技术
  • 毒理基因组学

第 11 章：全球体外毒性测试市场分析：依地理位置

  • 顶尖公司股票分析
  • 介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 12 章：体外毒性测试公司的竞争格局

  • 体外毒性测试市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 13 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Thermo Fisher Scientific Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Covance (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bio-Rad Laboratories Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GE Healthcare (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Eurofins Scientific SE (Luxembourg)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Merck KGaA (Germany)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Charles River Laboratories International Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Catalent Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cyprotex (UK)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • SGS SA (Switzerland)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • QIAGEN NV (Germany)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Promega Corporation (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Gentronix Limited (UK)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BioIVT (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • MB Research Laboratories (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR11218376

The global demand for In Vitro Toxicity Testing Market is presumed to reach the market size of nearly USD 34.34 MN by 2030 from USD 13.46 MN in 2022 with a CAGR of 12.42% under the study period 2023 - 2030.

In vitro toxicity testing is a research-based evaluation of the effects of toxic chemicals on cultured bacteria or mammalian cells. In vitro studies (i.e., in glass) are performed against microorganisms, cells, or biological molecules outside of normal biological conditions. When testing a drug in vitro, the concentration of the drug is limited to a known volume. This is critical because all drug behaviour assessments are essentially demonstrated at defined proportions. This is primarily done to assess the safety of drug development and chemical strength. The goal of toxicity testing is to develop data that can adequately protect public health from the adverse effects of exposure to environmental factors.

MARKET DYNAMICS:

The growth in technological advancement to evaluate drug safety, the upsurge in consumer goods safety, the increase in ranking and screening of potential drugs, and the rise in the number of in-vitro tests conducted are key industry drivers for in-vitro toxicology testing. In addition, increased investment in research and development and opposition to animal testing prompted in-vitro toxicology testing. However, the government's stringent regulations and a lack of professionals are significant barriers to in-vitro testing.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vitro toxicity testing. The growth and trends of in vitro toxicity testing industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the in vitro toxicity testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Covid Impact
  • Consumables
  • Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, Other Assays)
  • Equipment
  • Software
  • Services

By Method

  • Cellular Assays
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models

By Toxicity Endpoint & Test

  • ADME
  • Skin Irritation, Corrosion, & Sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Other Toxicity Endpoints & Tests

By Industry

  • Covid Impact
  • Pharmaceuticals & Biopharmaceuticals
  • Cosmetic & Household Products
  • Food
  • Chemicals

By Technology

  • Cell Culture Technologies
  • High-Throughput Technologies
  • Toxicogenomics

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the In Vitro Toxicity Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in vitro toxicity testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . IN VITRO TOXICITY TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Method
    • 3.7.3 Market Attractiveness Analysis By Toxicity Endpoint & Test
    • 3.7.4 Market Attractiveness Analysis By Industry
    • 3.7.5 Market Attractiveness Analysis By Technology
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5. IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY PRODUCT & SERVICE

  • 6.1 Overview by Product & Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product & Service
  • 6.4 Covid Impact Historic and Forecast Sales by Regions
  • 6.5 Consumables Historic and Forecast Sales by Regions
  • 6.6 Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays) Historic and Forecast Sales by Regions
  • 6.7 Equipment Historic and Forecast Sales by Regions
  • 6.8 Software Historic and Forecast Sales by Regions
  • 6.9 Services Historic and Forecast Sales by Regions

7 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY METHOD

  • 7.1 Overview by Method
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Method
  • 7.4 Cellular Assays Historic and Forecast Sales by Regions
  • 7.5 Biochemical Assays Historic and Forecast Sales by Regions
  • 7.6 In Silico Models Historic and Forecast Sales by Regions
  • 7.7 Ex Vivo Models Historic and Forecast Sales by Regions

8 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY TOXICITY ENDPOINT & TEST

  • 8.1 Overview by Toxicity Endpoint & Test
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Toxicity Endpoint & Test
  • 8.4 ADME Historic and Forecast Sales by Regions
  • 8.5 Skin Irritation, Corrosion, & Sensitization Historic and Forecast Sales by Regions
  • 8.6 Genotoxicity Testing Historic and Forecast Sales by Regions
  • 8.7 Cytotoxicity Testing Historic and Forecast Sales by Regions
  • 8.8 Ocular Toxicity Historic and Forecast Sales by Regions
  • 8.9 Organ Toxicity Historic and Forecast Sales by Regions
  • 8.10. Phototoxicity Testing Historic and Forecast Sales by Regions
  • 8.11 Dermal Toxicity Historic and Forecast Sales by Regions
  • 8.12 Other Toxicity Endpoints & Tests Historic and Forecast Sales by Regions

9 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY INDUSTRY

  • 9.1 Overview by Industry
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Industry
  • 9.4 Covid Impact Historic and Forecast Sales by Regions
  • 9.5 Pharmaceuticals & Biopharmaceuticals Historic and Forecast Sales by Regions
  • 9.6 Cosmetic & Household Products Historic and Forecast Sales by Regions
  • 9.7 Food Historic and Forecast Sales by Regions
  • 9.8 Chemicals Historic and Forecast Sales by Regions

10 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY TECHNOLOGY

  • 10.1 Overview by Technology
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Technology
  • 10.4 Cell Culture Technologies Historic and Forecast Sales by Regions
  • 10.5 High-throughput Technologies Historic and Forecast Sales by Regions
  • 10.6 Toxicogenomics Historic and Forecast Sales by Regions

11 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE IN VITRO TOXICITY TESTING COMPANIES

  • 12.1. In Vitro Toxicity Testing Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF IN VITRO TOXICITY TESTING INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Thermo Fisher Scientific Inc. (US)
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Covance (US)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Bio-Rad Laboratories Inc. (US)
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. GE Healthcare (US)
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Eurofins Scientific SE (Luxembourg)
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Merck KGaA (Germany)
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Charles River Laboratories International Inc. (US)
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Catalent Inc. (US)
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Cyprotex (UK)
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. SGS S.A. (Switzerland)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. QIAGEN N.V. (Germany)
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Promega Corporation (US)
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. Gentronix Limited (UK)
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments
  • 13.16. BioIVT (US)
    • 13.16.1. Company Overview
    • 13.16.2. Company Revenue
    • 13.16.3. Products
    • 13.16.4. Recent Developments
  • 13.17. MB Research Laboratories (US)
    • 13.17.1. Company Overview
    • 13.17.2. Company Revenue
    • 13.17.3. Products
    • 13.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Service (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays) Market Sales by Geography (USD MN)
  • Equipment Market Sales by Geography (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Method (USD MN)
  • Cellular Assays Market Sales by Geography (USD MN)
  • Biochemical Assays Market Sales by Geography (USD MN)
  • In Silico Models Market Sales by Geography (USD MN)
  • Ex Vivo Models Market Sales by Geography (USD MN)
  • Analysis by Toxicity Endpoint & Test (USD MN)
  • ADME Market Sales by Geography (USD MN)
  • Skin Irritation, Corrosion, & Sensitization Market Sales by Geography (USD MN)
  • Genotoxicity Testing Market Sales by Geography (USD MN)
  • Cytotoxicity Testing Market Sales by Geography (USD MN)
  • Ocular Toxicity Market Sales by Geography (USD MN)
  • Organ Toxicity Market Sales by Geography (USD MN)
  • Phototoxicity Testing Market Sales by Geography (USD MN)
  • Dermal Toxicity Market Sales by Geography (USD MN)
  • Other Toxicity Endpoints & Tests Market Sales by Geography (USD MN)
  • Analysis by Industry (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Pharmaceuticals & Biopharmaceuticals Market Sales by Geography (USD MN)
  • Cosmetic & Household Products Market Sales by Geography (USD MN)
  • Food Market Sales by Geography (USD MN)
  • Chemicals Market Sales by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Cell Culture Technologies Market Sales by Geography (USD MN)
  • High-throughput Technologies Market Sales by Geography (USD MN)
  • Toxicogenomics Market Sales by Geography (USD MN)
  • Global In Vitro Toxicity Testing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In Vitro Toxicity Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global In Vitro Toxicity Testing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Method
  • Market Attractiveness Analysis by Toxicity Endpoint & Test
  • Market Attractiveness Analysis by Industry
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays) Market Sales by Geography (USD MN)
  • Equipment Market Sales by Geography (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Method (USD MN)
  • Cellular Assays Market Sales by Geography (USD MN)
  • Biochemical Assays Market Sales by Geography (USD MN)
  • In Silico Models Market Sales by Geography (USD MN)
  • Ex Vivo Models Market Sales by Geography (USD MN)
  • Global Market Analysis by Toxicity Endpoint & Test (USD MN)
  • ADME Market Sales by Geography (USD MN)
  • Skin Irritation, Corrosion, & Sensitization Market Sales by Geography (USD MN)
  • Genotoxicity Testing Market Sales by Geography (USD MN)
  • Cytotoxicity Testing Market Sales by Geography (USD MN)
  • Ocular Toxicity Market Sales by Geography (USD MN)
  • Organ Toxicity Market Sales by Geography (USD MN)
  • Phototoxicity Testing Market Sales by Geography (USD MN)
  • Dermal Toxicity Market Sales by Geography (USD MN)
  • Other Toxicity Endpoints & Tests Market Sales by Geography (USD MN)
  • Global Market Analysis by Industry (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Pharmaceuticals & Biopharmaceuticals Market Sales by Geography (USD MN)
  • Cosmetic & Household Products Market Sales by Geography (USD MN)
  • Food Market Sales by Geography (USD MN)
  • Chemicals Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Cell Culture Technologies Market Sales by Geography (USD MN)
  • High-throughput Technologies Market Sales by Geography (USD MN)
  • Toxicogenomics Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.